A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionap4hnqpudjo9oh9q0gemuhalf5l98rj0): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

G.H.); and National Institute of Neurol... Publications | LitMetric

2,167 results match your criteria: "G.H.); and National Institute of Neurological Disorders and Stroke (R.T.B.)[Affiliation]"

Diagnosis and Management of Noncardiac Chest Pain.

Gastroenterol Hepatol (N Y)

October 2024

Division of Gastroenterology, Mayo Clinic Florida, Jacksonville, Florida.

Noncardiac chest pain is a challenging condition often encountered by primary care providers, emergency medicine physicians, and gastroenterologists. It is frequently accompanied by persistent symptoms, diagnostic uncertainty, decreased quality of life, and high health care burden. Gastroesophageal reflux disease is the most common esophageal cause followed by functional chest pain, and at least half of patients with noncardiac chest pain have psychiatric comorbidities such as anxiety or depression.

View Article and Find Full Text PDF

Clarifying the Hazy Concepts of Food Allergies and Sensitivities.

Gastroenterol Hepatol (N Y)

October 2024

Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida.

Article Synopsis
  • Food allergies, sensitivities, and adverse reactions are frequent reasons for referral to specialists, with their prevalence increasing and public awareness rising.
  • Symptoms often don't align with actual causes, leading to costly and unhelpful tests.
  • The article clarifies the differences between food allergies and sensitivities, covering their prevalence, causes, symptoms, diagnosis, and treatment options.
View Article and Find Full Text PDF

Highlights From the Recent AASLD Practice Guidelines on Noninvasive Assessment of Hepatic Fibrosis and Steatosis.

Gastroenterol Hepatol (N Y)

October 2024

VCU Hepatology Professor of Medicine Chief, Section of Hepatology Chief Clinical Officer, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health Assistant Chair for Research, Department of Medicine Virginia Commonwealth University Richmond, Virginia.

View Article and Find Full Text PDF

Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel Disease.

Gastroenterol Hepatol (N Y)

July 2024

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Article Synopsis
  • Patients with inflammatory bowel disease (IBD) face high out-of-pocket costs, reaching up to $41,000 annually, primarily due to expensive biologic medications.
  • Biologics are effective for treating IBD, but their high costs create a need for more affordable alternatives like biosimilars, which are FDA-approved and offer similar therapeutic benefits at a lower price.
  • Despite the advantages of biosimilars, such as increased access and cost-effectiveness, their usage in the U.S. has been limited, prompting a need for better guidance on transitioning to these alternatives in clinical practice.
View Article and Find Full Text PDF

The Suggested Relationships Between Common GI Symptoms and Joint Hypermobility, POTS, and MCAS.

Gastroenterol Hepatol (N Y)

August 2024

Division of Gastroenterology and Hepatology, Lynda K. and David M. Under wood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas.

An increasing number of reports suggest an association between a newly recognized disease cluster and significant and often disabling gastrointestinal (GI) symptoms. This cluster is composed of diagnoses of hypermobility spectrum disorders (HSDs) such as joint hypermobility and hypermobile variant Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS). The diagnosis of these entities remains a challenge, as the pathophysiology of each has not been completely elucidated and the diagnostic criteria continue to evolve.

View Article and Find Full Text PDF

Current Status of Genetics and Polygenic Risk Scores in Metabolic Dysfunction-Associated Steatohepatitis.

Gastroenterol Hepatol (N Y)

August 2024

Vice President for Academic Affairs, Indiana University Health David W. Crabb Professor of Gastroenterology and Hepatology Adjunct Professor of Anatomy, Cell Biology and Physiology Indiana University School of Medicine Indianapolis, Indiana.

View Article and Find Full Text PDF

infection affects over half of the world's population and is a global health concern because it contributes to chronic and fatal gastrointestinal disorders, including peptic ulcer disease and gastric cancer. The escalating prevalence of antibiotic-resistant strains of necessitates a change in management. The conventional strategy of empiric-based treatments is becoming increasingly ineffective in both adult and pediatric populations; rates of eradication to common first-line regimens remain suboptimal and continue to decline.

View Article and Find Full Text PDF